MAP3K8 Antikörper (pThr290)
Kurzübersicht für MAP3K8 Antikörper (pThr290) (ABIN2625107)
Target
Alle MAP3K8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pThr290
-
Spezifität
- This MAP3K8 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T290 of human MAP3K8.
-
Aufreinigung
- Affinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: DB (1:500), ELISA (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Andere Bezeichnung
- MAP3K8 / TPL2
-
Hintergrund
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
Gen-ID
- 1326
-
Pathways
- PI3K-Akt Signalweg, T-Zell Rezeptor Signalweg
Target
-